The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
This study has been terminated.
First Posted: June 25, 2012
Last Update Posted: August 22, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||May 2017|
|Primary Completion Date:||February 2017 (Final data collection date for primary outcome measure)|